Familial dysalbuminaemic hyperthyroxinaemia (FDH) can be confused with thyrotoxicosis if clinical signs and laboratory tests are misinterpreted. We describe three members of the same family with FDH who were erroneously treated for thyrotoxicosis. Screening of other family members resulted in the discovery of a further six patients at risk of being misdiagnosed as thyrotoxic. Clinical and biochemical findings relevant to the diagnosis of FDH are discussed.
Introduction
Familial dysalbuminaemic hyperthyroxinaemia (FDH) is a recently described condition in which albumin molecules have a greatly increased affinity for thyroxine (T4) resulting in elevated levels of total T4 but normal levels of the free, active hormone.' Affected individuals are euthyroid but at risk of being diagnosed as thyrotoxic. We describe three members of the same family with FDH who were erroneously treated for thyrotoxicosis. Thyroid function tests were carried out on other family members and a further six patients at risk of being misdiagnosed as thyrotoxic identified. A 49 year old man, the uncle of Patient 1, was seen in another hospital in April 1984 with a long history of anxiety and palpitations induced by stress or exertion. There were no other symptoms suggestive of thyroid disease. On examination he was euthyroid and a goitre was not palpable. A diagnosis of anxiety attacks was made and he was commenced on propranolol. Results of thyroid function tests were: T4 248 nmol/l (normal 50-150), T3 1.9nmol/l (normal 1.1-2.8) and T4 to TBG ratio 13 (normal 3-9). He was treated with carbimazole and propranolol for 6 months with some symptomatic relief. A month after discontinuing the carbimazole, serum T4 was again elevated and in May 1985 he was treated with radioactive iodine (225 MBq). Three months later he was clinically euthyroid and serum values of both T4 and TSH were elevated at 206 nmol/l and 7.9 mU/l (normal 0.5-6.5) respectively. He was followed in outpatients but received no further treatment. The diagnosis of FDH was made in him after it had been confirmed in his niece (Patient 1).
Patient 3
The 41 year old mother of Patient 1 and sister of Patient 2 was referred for specialist opinion at another hospital because of some years of feeling generally unwell with headache, malaise, anorexia and latterly some weight loss. On examination she was euthyroid and a goitre was not palpable. As part of a routine screening battery thyroid function tests were carried out and these showed: T3 uptake 108 (normal 92-117), T4 210 nmol/l (normal 60-156) and free thyroxine index (FTI) 194 (normal 65-130). In October 1984 she was commenced on carbimazole 30 mg/day with little reliefofher symptoms. By January 1985 T3 uptake was 120, T4 65 nmol/l, FTI 54 and TSH 35 mU/l (normal 0-6). Carbimazole was discontinued. When she complained offeeling exhausted a month later carbimazole treatment was recommenced. The drug was again withdrawn 6 months later when serum T4 was< 34 nmol/l and TSH > 51 mU/l. Her presenting symptoms persisted and the diagnosis of FDH was finally made only after it had been arrived at in her daughter (Patient 1).
Results of screening three generations ofthe family are presented in Figure 1 . Transmission was by the mother of Patients 2 and 3 and four of her eight children were affected. Of 11 children in the third generation born to affected parents, four were shown to have FDH, five were normal and two were not tested. The pattern of inheritance is consistent with autosomal dominant transmission as has been previously described.?3 Another of the affected family members had already been referred to medical outpatients as possibly thyrotoxic because of the strong family history of this disease. Fortunately the initial laboratory tests were correctly interpreted as showing FDH.
Discussion
Serum total thyroxine may be elevated either in thyrotoxicosis or when the concentration of T4-binding proteins is increased. An elevated TBG, the principal protein binding both T3 and T4 is routinely tested for in many clinical laboratories either directly or by thyroid hormone uptake tests. In FDH albumin has increased affinity for T4 and sometimes T3."4 Under these circumstances total T4 is elevated and TBG normal so that the T4/TBG ratio will also be raised and the incorrect diagnosis of thyrotoxicosis may be made. When T3 uptake tests are used patients with albumin that binds only T4 will give normal results so that the FTI will also be misleadingly raised. To date three distinct albumin variants with enhanced affinity for T4 have been described. 4 Patients with FDH will not be mistakenly diagnosed as having thyrotoxicosis if proper attention is paid to both clinical examination and the results of routine laboratory tests of thyroid function.
Clinically these patients are euthyroid and the response to treatment with T4, T3, potassium iodide, or subtotal thyroidectomy supports the concept that the elevated levels of T4 are an appropriate response to increased binding of this hormone.5 None of the patients described above was clinically thyrotoxic.
While T4 and FTI are elevated in FDH, serum free thyroxine levels measured by equilibrium dialysis are normal' although the levels measured by most of the commonly used analogue assays are misleadingly high4 as was found in Patient 1. Serum total T3 is l Unaffected male WV Affected male .e usually in the normal range as is free T3' but there is one albumin variant which binds increased amounts of both T3 and T4 resulting in elevated total levels of both these substances. The diagnosis of FDH was suggested in Patients 1 and 2 by the normal T3 levels which are surprising in thyrotoxicosis and usually only found in elderly patients with other serious systemic diseases6 or in other types of euthyroid hyperthyroxinaemia.7 In Patient 3 the T3 uptake was towards the upper end of the normal range suggesting the presence of an abnormal binding protein. In laboratories using high sensitivity TSH assays, the finding of detectable TSH in a patient with a raised T4 concentration makes the diagnosis of thyrotoxicosis unlikely.
If the diagnosis of FDH is suspected a screening test can be used in which the increased binding ofT4 by the abnormal albumin is detected by adding excess T4 to the patient's serum to saturate the TBG together with a trace amount of '25I-T4. The fraction of T4 not bound to the serum proteins is absorbed by dextran coated charcoal. Patients with FDH show increased binding of radioactive T4 when compared to normals.3 Confirmation of a positive result, and the definitive diagnosis, can be made by the use of reverse flow electrophoresis.S Use of these tests may prevent other patients receiving unnecessary and at times hazardous treatment for non-existent thyrotoxicosis.
